Concepedia

Margaux Boehler

MB

5

Publications

142

Citations

5

H-Index

2016

Active since

Affiliations

Actelion (Switzerland)(Current)

Idorsia (Switzerland)

Margaux Boehler is an author at Actelion (Switzerland) specializing in medicine, pharmacodynamic modeling, and cell death.

Top concepts

Publications per year

2016–2019

5

Publications

5

Decitabine Treatment of Glioma-Initiating Cells Enhances Immune Recognition and Killing

Cristina Riccadonna, Céline Yacoub Maroun, Romain Vuillefroy de Silly et al. · PLoS ONE · 2016 · 40 citations · Full text

, , +16

Clinical Pharmacology of the Reversible and Potent P2Y<sub>12</sub> Receptor Antagonist ACT‐246475 After Single Subcutaneous Administration in Healthy Male Subjects

Pierre‐Éric Juif, Margaux Boehler, Michael Dobrow et al. · The Journal of Clinical Pharmacology · 2018 · 35 citations

Clinical pharmacology of the dual orexin receptor antagonist ACT-541468 in elderly subjects: Exploration of pharmacokinetics, pharmacodynamics and tolerability following single-dose morning and repeated-dose evening administration

Clemens Muehlan, Margaux Boehler, Sander Brooks et al. · Journal of Psychopharmacology · 2019 · 33 citations

A pharmacokinetic drug–drug interaction study between selexipag and midazolam, a CYP3A4 substrate, in healthy male subjects

Pierre‐Éric Juif, Margaux Boehler, Yves Donazzolo et al. · European Journal of Clinical Pharmacology · 2017 · 18 citations

, , +8

Effect of gemfibrozil and rifampicin on the pharmacokinetics of selexipag and its active metabolite in healthy subjects

Shirin Bruderer, Marc Petersen‐Sylla, Margaux Boehler et al. · British Journal of Clinical Pharmacology · 2017 · 16 citations · Full text

Rows per page

1–5 of 5